AJCC |
American Joint Committee on Cancer |
SNP |
Single Nucleotide Polymorphism |
BCG |
Bacillus Calmette–Guérin |
SLN |
Sentinel lymph node |
DFS |
Disease free survival |
HR |
Hazard ratio |
OS |
Overall survival |
IL |
Interleukin |
ICI |
Immune Checkpoint Inhibitors |
GM-CSF |
Granulocyte-macrophage colony-stimulating factor |
TLR |
Toll-Like Receptor |
MSLT-I |
Multicenter Selective Lymphadectomy |
MMAIT |
Malignant Melanoma Active Immunotherapy Trial |
TNF |
Tumor necrosis factor |
CCR5 |
C-C chemokine receptor type 5 |
CXCL12 |
C-X-C motif chemokine 12 |
NRAMP1 |
natural resistance-associated macrophage protein 1 |
SLC11A1 |
solute carrier protein 11A1 |
CD209 |
Cluster of Differentiation 209 |
DC-SIGN |
Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin |
BTNL2 |
Butyrophilin Like 2 |
PCA |
Principal Component Analysis |
DTH |
Delayed Type Hypersensitivity |
PPD |
Purified Protein Derivative |
VEGF |
Vascular Endothelial Factor |
pDC |
Plasmacytoid Dendritic Cells |
CT |
Computed Tomography |
MRI |
Magnetic Resonance Imaging |
ECOG |
Eastern Cooperative Oncology Group |
PBL |
Peripheral Blood Leukocytes |
IRB |
Institutional Review Board |
DTH |
Delayed Type Hypersensitivity |
MIP |
Macrophage Inflammation Protein |
TB |
Tuberculosis |
ECOG |
Eastern Cooperative Oncology Group |
CLND |
Complete Lymph Node Dissection |